v3.26.3
SHAREHOLDERS' EQUITY - Narrative (Details)
3 Months Ended 6 Months Ended 91 Months Ended
Feb. 04, 2020
USD ($)
sales_agent
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 01, 2026
shares
Aug. 31, 2026
shares
May 19, 2026
USD ($)
Mar. 31, 2026
shares
May 21, 2024
USD ($)
Aug. 02, 2022
USD ($)
Aug. 31, 2021
USD ($)
Jul. 28, 2021
USD ($)
May 26, 2021
USD ($)
Mar. 04, 2019
USD ($)
Subsidiary or Equity Method Investee [Line Items]                                
Common stock, authorized (in shares) | shares   135,000,000   135,000,000   135,000,000 135,000,000 75,000,000   75,000,000            
Repurchase authorized amount                         $ 20,000,000 $ 20,000,000    
Equity ATM Program                                
Subsidiary or Equity Method Investee [Line Items]                                
Maximum consideration threshold $ 100,000,000.0               $ 2,000,000,000.0   $ 1,000,000,000.0 $ 650,000,000.0     $ 250,000,000.0 $ 50,000,000.0
Number of additional sales agents | sales_agent 2                              
Gross sales commission percentage 2.00%                           1.50%  
Number of shares sold (in shares) | shares   2,732,562 1,766,975 5,441,000 3,801,892 45,878,289                    
Weighted average price per share (in usd per share) | $ / shares   $ 24.50 $ 22.81 $ 23.99 $ 21.58 $ 21.81                    
Gross proceeds received   $ 66,960,000 $ 40,304,000 $ 130,526,000 $ 82,028,000 $ 1,000,700,000                    
Net proceeds received   66,020,000 $ 39,699,000 128,663,000 $ 80,896,000 985,500,000                    
Available under the equity ATM program   $ 999,300,000   $ 999,300,000   $ 999,300,000